The newly formed Nevada Cannabis Compliance Board says that it has opened an investigation into three Las Vegas dispensaries for selling a product that twice failed testing for microbial contaminants.
The product is Cherry OG F3, which all dispensaries and retail stores were told to stop selling immediately after it failed testing for yeast and mold, coliforms, Enterobacteriaceae and aspergillus on March 5, 2020.
Enterobacteriaceae is a group of bacteria that can cause infections and even pneumonia. Aspergillus is a fungus whose spores can cause infections most commonly in those with sensitive lungs.
RELATED| Cannabis Compliance Board hits two valley dispensaries with non-compliance complaints
In March, all dispensaries and stores were told to destroy or return Cherry OG F3 to the cultivator and tell the state which action they took.
Despite the CCB’s directive, the three dispensaries apparently retained the Cherry OG strain and started to sell it again in May.
Roughly 375 grams of the product was sold between May 19 and June 29 from Jenny’s Dispensary (5530 N. Decatur Boulevard), Las Vegas ReLeaf (2244 Paradise Road) and Sahara Wellness (420 E. Sahara Avenue).
According to CCB, a hold on the product was temporarily lifted due to an error during an unrelated investigation on May 16. Still, the health and safety advisory was in effect and should have prevented the dispensaries from selling the product.
Those who have purchased Cherry OG F3 should avoid consuming it. The source package for any Cherry OG products should be checked for # 1A404030000076F000006649.